Anavex Life Sciences (AVXL) - News Mentions

Sign up to add (AVXL) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 2 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 100%
BridgeBio Pharma
BridgeBio Pharma
BBIO		 0 100%
Critical Analysis: Palisade Bio (NASDAQ:PALI) vs. Anavex Life Sciences (NASDAQ:AVXL)
November 16
Anavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval Scenario
November 5
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by China Universal Asset Management Co. Ltd.
November 1
Anavex Life Sciences : Phase IIb/III Trial of Blarcamesine in Early Alzheimer Disease Demonstrates Pre-specified Clinical Efficacy Through Upstream SIGMAR1 Activation
October 30
Anavex Life Sciences’ Promising Alzheimer’s Drug: Buy Rating Justified by Positive Clinical Outcomes and Strategic Advantages
October 30
The Manufacturers Life Insurance Company Raises Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)
October 20
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from HC Wainwright
October 19
Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from HC Wainwright
October 18
Buy Rating Affirmed for Anavex Life Sciences Amid Promising Clinical Developments and Market Prospects
October 17
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
October 17
Anavex Life Sciences Corp. (NASDAQ:AVXL) Sees Significant Decline in Short Interest
October 15
Squarepoint Ops LLC Buys New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
October 14
Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
October 9
Renaissance Technologies LLC Raises Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
October 3
Renaissance Technologies LLC Purchases 386,537 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)
October 3
Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
November 10

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is Anavex Life Sciences mentioned in the news?

Anavex Life Sciences was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Anavex Life Sciences performing compared to its industry peers?

Anavex Life Sciences underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Anavex Life Sciences in the last month?

Anavex Life Sciences' was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Anavex Life Sciences?

By monitoring mentions in the news for Anavex Life Sciences, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Anavex Life Sciences, ultimately improving their investment strategies.

Sign up and get more insights on Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact